Navigation Links
BiondVax to Present Tomorrow at Joseph Gunner Pioneers 2016 Conference
Date:5/4/2016

NESS ZIONA, Israel, May 4, 2016 /PRNewswire/ --

BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV, TASE: BVXV) announced today that BiondVax's CEO, Dr. Ron Babecoff, will be attending the Joseph Gunnar Pioneers 2016 conference in New York City.

On Thursday, May 5, Dr. Babecoff will be presenting at 10:30am at Pioneers 2016, a conference presented by Joseph Gunner & Co, taking place at the New York Palace Hotel.

The BiondVax presentation that Dr. Babecoff will be using is downloadable from BiondVax's website: http://www.biondvax.com/investor-presentation. Those wishing to meet one-on-one with Dr. Babecoff are invited to contact BiondVax.

About BiondVax Pharmaceuticals Ltd 

BiondVax is a biopharmaceutical company developing a universal flu vaccine. The vaccine is designed to provide multi-season protection against most seasonal and pandemic human influenza virus strains. BiondVax's proprietary technology utilizes a unique combination of conserved and common peptides from influenza virus proteins, activating both arms of the immune system for a cross-protecting and long-lasting effect. BiondVax is traded on NASDAQ: BVXV and TASE: BVXV. For more information, please visit http://www.biondvax.com.

Forward Looking Statements 

This press release contains forward-looking statements within the meaning of the Private Litigation Reform Act of 1995. Words such as "expect," "believe," "intend," "plan," "continue," "may," "will," "anticipate," and similar expressions are intended to identify forward-looking statements. These forward-looking statements involve certain risks and uncertainties reflect the management's current views with respect to certain current and future events and are subject to various risks, uncertainties and assumptions that could cause the results to differ materially from those expected by the management of BiondVax Pharmaceuticals Ltd. risks and uncertainties include, but are not limited to, the risk that drug development involves a lengthy and expensive process with uncertain outcome. The risks, uncertainties and assumptions referred to above are discussed in detail in our reports filed with the Securities and Exchange Commission, including our Prospectus which was declared effective on May 11, 2015. BiondVax Pharmaceuticals Ltd. undertakes no obligation to update or revise any forward-looking statements. 

For further information, please contact:  


Company Contact
Joshua Phillipson
Business Development Manager
+972-8-930-2529 x5105
j.phillipson@biondvax.com


Investor Relations Contact
GK Investor Relations
Kenny Green, Partner
+1-646-201-9246
kenny@biondvax.com


'/>"/>
SOURCE BiondVax Pharmaceuticals Ltd.
Copyright©2016 PR Newswire.
All rights reserved


Related medicine technology :

1. BiondVax CEO to Present at Roth Conference on Wednesday, March 16
2. BiondVax Receives Additional Grant Approval
3. Biondvaxs Universal Flu Vaccine Receives Additional US Patent
4. BiondVax to Present on October 8 at the Aegis Growth Conference
5. BiondVax to Present on September 10 at the Rodman & Renshaw Global Investment Conference
6. Independent Results Show that BiondVaxs Universal Flu Vaccine Administered in a Trial 3 Years ago Improves Immunogenicity Against Current Flu H3N2 Epidemic
7. BiondVax Presents BVX-006 Preliminary Phase II Results: the Universal Flu Vaccine at Higher Doses is Safe and Improves Immunogenicity in Older Adults
8. BiondVax Pharmaceuticals Ltd. Announces a Closing of Over-Allotment Option
9. Oramed to Present at PIONEERS 2016, Presented by Joseph Gunnar
10. TapImmune to Present at the 3rd Annual Growth Capital Expo in Las Vegas on May 4, 2016
11. Q BioMed Inc. to Present at the Global Chinese Financial Forum on April 30, 2016
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/12/2019)... ... June 12, 2019 , ... Through their Sidewalk Angels Foundation (SWA), Marisol ... importance of protecting your entire family from Lyme and other tick-borne diseases. We are ... fur we have. , Through this partnership SWA and GLA look to raise ...
(Date:6/11/2019)... ... , ... Today NASH kNOWledge hosted a Liver Disease Information ... Steatohepatitis (NASH) Day, a global effort in the fight against NASH. Community leaders ... what they can do to help. The event also included a pre-screening of ...
(Date:6/11/2019)... China, and SAN DIEGO (PRWEB) , ... June ... ... and fully integrated global Contract Development and Manufacturing Organization (CDMO) serving the global ... announced the appointment of Wei Chen, Ph.D as the company's new Chief Executive ...
Breaking Medicine Technology:
(Date:6/14/2019)... N.J. (PRWEB) , ... June 14, 2019 , ... FL Top Docs is proud to present the following recently reviewed and approved providers for May ... Dietrick , BREAST SURGERY, Dr. Debbie Berlin ... Khan , Dr. Christopher J. Pastore , Dr. Yamilet Tirado ...
(Date:6/13/2019)... ... ... painful, inflammatory disease that occurs when tissue grows outside of the uterus. The symptoms of ... , Irregular menstruation , Severe cramps , Back pain ... treatment protocols in dealing with the symptoms of endometriosis. In the past, a total hysterectomy, ...
(Date:6/13/2019)... (PRWEB) , ... June 13, 2019 , ... Women’s Excellence in Obstetrics and Gynecology specializes ... conditions, some that may be difficult to diagnosis. Women’s Excellence handles routine and complicated ... cysts , Endometriosis , Heavy periods , Adhesions (scar ...
(Date:6/13/2019)... ... June 13, 2019 , ... In Partnership with the ... for low-income, underinsured individuals at its Mesquite, TX office on July 13th. , Dental ... cleanings and extractions . For more information, please visit the Monarch ...
(Date:6/13/2019)... ... , ... Hard money lenders like Monroe Funding Corporation are able to respond ... provided quickly. If the documentation and collateral are immediately available, it’s possible to receive ... oversight involved with a traditional lender, which allows loans to be customized and adjusted ...
Breaking Medicine News(10 mins):